Fig. 3
From: Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease
Three potential alternative therapeutics in ischemic vascular disease: growth factor-based therapy, cell-based therapy, and material-based therapy including nanomedicine and biomaterials. HGF: hepatocyte growth factor; FGF: fibroblast growth factor; PDGF: platelet-derived growth factor; VEGF: vascular endothelial growth factor; MSCs: mesenchymal stem cells; EPCs: endothelial progenitor cells; iPSCs: induced pluripotent stem cells. The figure was constructed with BioRender (https://biorender.com)